about
Diagnosis of Plasmodium falciparum Malaria at Delivery: Comparison of Blood Film Preparation Methods and of Blood Films with HistologyMaternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi.Malaria during pregnancy and foetal haematological status in Blantyre, MalawiA randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant womenIntermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialPerformance characteristics of combinations of host biomarkers to identify women with occult placental malaria: a case-control study from MalawiPTEX is an essential nexus for protein export in malaria parasitesSeverity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study.Antibody to P. falciparum in pregnancy varies with intermittent preventive treatment regime and bed net use.What is the relationship between haptoglobin, malaria, and anaemia?CCR5 haplotypes and mother-to-child HIV transmission in Malawi.Disruption of var2csa gene impairs placental malaria associated adhesion phenotype.Placental hypoxia during placental malaria.Severe vivax malaria: newly recognised or rediscoveredDifferential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area.Population hemoglobin mean and anemia prevalence in Papua New Guinea: new metrics for defining malaria endemicity?Pharmacokinetic properties of azithromycin in pregnancyUsing an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria.Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed netsPharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy.Cross-reactive surface epitopes on chondroitin sulfate A-adherent Plasmodium falciparum-infected erythrocytes are associated with transcription of var2csa.Intermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and deliveryImmunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.Independent lineages of highly sulfadoxine-resistant Plasmodium falciparum haplotypes, eastern Africa.Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women.Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, MalawiEvaluation of the OptiMAL rapid antigen test and species-specific PCR to detect placental Plasmodium falciparum infection at delivery.Relevant assay to study the adhesion of Plasmodium falciparum-infected erythrocytes to the placental epithelium.Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes.Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity.Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction.Selective accumulation of mature asexual stages of Plasmodium falciparum-infected erythrocytes in the placenta.HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytesMalaria in pregnancy in the Asia-Pacific region.Parasite adhesion and immune evasion in placental malaria.Antibody response against three Plasmodium falciparum merozoite antigens in Mamuju District, West Sulawesi Province, Indonesia.Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women.Does malaria affect placental development? Evidence from in vitro modelsPlasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transportDelivery of the malaria virulence protein PfEMP1 to the erythrocyte surface requires cholesterol-rich domains.
P50
Q15295131-B34117BD-95B3-480D-9541-8C1CA58FC456Q24810804-122DE809-A48D-47C4-AEC9-43A832F218B9Q24815923-C2D0FA9B-46B9-4FFA-A8F2-140BCD3685BBQ28469347-18A09325-35A7-4C70-B711-B1AA356745BBQ28481649-A3A24C44-26D3-4A17-A0D9-D76448B7B24DQ28741606-D764C275-73D5-4FD4-97A2-32B6A7584E9DQ30042849-FD68FB2F-9A21-4C8E-8E0B-59994F67ACACQ30222338-CD955A2E-2AD9-46C2-A779-191980779071Q31047525-8AD0FB4A-750B-479F-848F-60637834092CQ33241039-986E7295-6502-480C-ADF5-083AF88375D5Q33296998-5DFB769D-57F9-40C6-B306-530BA641D615Q33299476-449FDCDA-D386-4612-91AF-555B80FA2FAAQ33320054-858BA1F9-E7B6-47F9-ADD6-536D9ADCA0B7Q33344909-21734CE8-3B5D-4A7E-8ED7-E3B1143D0D61Q33532592-841782B0-DE88-4A72-B2E3-1AC3CB51A114Q33535802-E06299FC-4561-4766-8BC5-D824819982FCQ33558917-CD1F28CF-5137-4703-B7D7-B92DBA1E8675Q33593182-2788BA08-6F68-4CCB-8081-621FFAE2FCE0Q33654066-3C53ADCE-E84A-4BF8-B4E3-A660A7D7C07AQ33676120-F30E1CA2-51DC-4981-87D5-0E04D8253032Q33769127-590E181A-F935-482D-AC95-02DB0EBDBD22Q33815505-C1475DF1-11FC-4548-8BCB-D41CF20AD793Q33815803-308D9A2B-CC6B-4FE7-B5D4-B6D18B2AD300Q33816411-A9556967-CFAA-4579-84C5-9E2658AF5541Q33826049-46E03851-DFE6-44BB-B67D-2DE20FBCCBEFQ33935361-9E4C9B33-9320-4068-BEC1-A6DFFC21F183Q33947045-7D7700A3-CBA2-432E-A155-D8A1EC854E9EQ33952181-0CBD65B0-A5FE-4411-889B-BBFFC911CEDCQ33980021-76817D41-7064-4125-AA33-60CF00B91C05Q34034060-58B32F9F-CB0D-4160-98A2-A1D7CCFCEBA6Q34037890-848B6321-F3B7-46DA-A8B6-BD3B55B909E4Q34132871-AE9DD1C9-D2A3-4BEF-8A96-FE69BD015F5DQ34171651-DDF7AE06-D0CF-4415-8BDD-D5A8A454D454Q34242348-EF3F2C5E-0294-4126-A0A0-425DB37DBF94Q34292107-4F4921EB-AA26-4A4B-9901-22B73CE40E83Q34320287-48858C37-DD2E-4E1C-BF55-B5777FBB0E80Q34530051-D593A0B4-84E0-43F2-93EB-7368AA122F0CQ34576303-1CFB05B1-9D08-4F46-B37B-5C58F9063A61Q34585683-BB6CA038-E2D3-44DF-A7DB-505B7C848468Q34601627-6D67F174-7D62-41C8-8BAC-C51DC0FB0A2D
P50
description
researcher ORCID: 0000-0003-4287-1982
@en
wetenschapper
@nl
name
Stephen J Rogerson
@nl
Stephen J Rogerson
@sl
Stephen J. Rogerson
@en
Stephen J. Rogerson
@es
type
label
Stephen J Rogerson
@nl
Stephen J Rogerson
@sl
Stephen J. Rogerson
@en
Stephen J. Rogerson
@es
altLabel
Stephen J Rogerson
@en
prefLabel
Stephen J Rogerson
@nl
Stephen J Rogerson
@sl
Stephen J. Rogerson
@en
Stephen J. Rogerson
@es
P108
P106
P1153
7005690292
P21
P31
P496
0000-0003-4287-1982